New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Volunteering for Cancer Research: An Act of Love Penn Medicine News News | May 2025 Genomic Profiling Reveals Key Differences in Prostate Cancer World News Today News | May 2025 Oncology Experts Highlight Top Takeaways From the 2025 AACR Annual Meeting OncLive News | May 2025 Raising Awareness of the BRCA Gene Among the Jewish Community Jewish Telegraphic Agency News | April 2025 ASCO Honors Penn Professor for Cancer Prevention Research HemOnc Today News | April 2025 Cancer Risk in BRCA-Positive Men Spotify News | March 2025 Dr. Nathanson on the Role of Reversion Mutations in PARP Inhibitor Resistance in Breast Cancer OncLive News | March 2025 Four Penn Cancer Researchers Elected as Fellows of the AACR Academy Penn Medicine News News | March 2025 Dr. Nathanson on Next Steps for Identifying Novel Resistance Mechanisms in Breast Cancer OncLive News | February 2025 Who Needs a BRCA Gene Test? New Beauty News | February 2025 ASCO to Honor Oncology Leaders Becker’s Hospital Review News | January 2025 Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work Penn Medicine News News | January 2025 The Future of Cancer Genetics is Here Medical Digest News | January 2025 New Tool Puts Reproductive Risk for BRCA Carriers into Perspective Penn Medicine News News | December 2024 Sung Honored for Cancer Research ASBMB Today News | December 2024 Mid Penn Bank Donates $100,000 to Basser Center for BRCA at Penn Medicine Penn Watch News | December 2024 Men Need to Worry About BRCA Mutations Too The Atlantic News | November 2024 One-Stop Shops for Patients with BRCA Mutations Medscape News | November 2024 Pagination First page« First Previous page‹‹ Page1 Current page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
Raising Awareness of the BRCA Gene Among the Jewish Community Jewish Telegraphic Agency News | April 2025
Dr. Nathanson on the Role of Reversion Mutations in PARP Inhibitor Resistance in Breast Cancer OncLive News | March 2025
Four Penn Cancer Researchers Elected as Fellows of the AACR Academy Penn Medicine News News | March 2025
Dr. Nathanson on Next Steps for Identifying Novel Resistance Mechanisms in Breast Cancer OncLive News | February 2025
Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work Penn Medicine News News | January 2025
New Tool Puts Reproductive Risk for BRCA Carriers into Perspective Penn Medicine News News | December 2024
Mid Penn Bank Donates $100,000 to Basser Center for BRCA at Penn Medicine Penn Watch News | December 2024
